BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2021 12:09:57 PM | Browse: 877 | Download: 1803
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 64702
Country Hungary
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system
Manuscript Source Invited Manuscript
All Author List Zoltan Herold, A Marcell Szasz and Magdolna Dank
ORCID
Author(s) ORCID Number
Zoltan Herold http://orcid.org/0000-0001-5990-4889
A Marcell Szasz http://orcid.org/0000-0003-2739-4196
Magdolna Dank http://orcid.org/0000-0002-4694-3624
Funding Agency and Grant Number
Funding Agency Grant Number
UNKP-20-4-I New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund
Corresponding Author Magdolna Dank, MD, PhD, Professor, Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, Tomo u. 25-29, Budapest H-1083, Hungary. dank.magdolna@med.semmelweis-univ.hu
Key Words Hyperthermia induced; Carcinoma hepatocellular; Cholangiocarcinoma; Gallbladder neoplasms; Pancreatic neoplasms
Core Tip Adjuvant hyperthermia is beneficial in hepatopancreatobiliary cancers due to its direct and indirect anti-tumoral effects. Higher response rate to treatment, longer survival, and improved laboratory and quality of life data has been observed in several randomized and observational clinical trials on various hyperthermia methods. The routine use of hyperthermia in cancer care has not emerged yet. In this review, the clinical data on hyperthermia in hepatopancreatobiliary tumors is summarized, focusing mainly on results that have the most clinical and research interest.
Publish Date 2021-09-10 12:09
Citation Herold Z, Szasz AM, Dank M. Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system. World J Gastrointest Oncol 2021; 13(9): 1109-1120
URL https://www.wjgnet.com/1948-5204/full/v13/i9/1109.htm
DOI https://dx.doi.org/10.4251/wjgo.v13.i9.1109
Full Article (PDF) WJGO-13-1109.pdf
Full Article (Word) WJGO-13-1109.docx